Follow
Rick Kennedy
Rick Kennedy
Professor of Medicine, Mayo Clinic
Verified email at mayo.edu
Title
Cited by
Cited by
Year
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
GA Poland, IG Ovsyannikova, RB Kennedy
The Lancet 396 (10262), 1595-1606, 2020
6762020
Multiple roles for CD4+ T cells in anti‐tumor immune responses
R Kennedy, E Celis
Immunological reviews 222 (1), 129-144, 2008
6122008
Immunosenescence and human vaccine immune responses
SN Crooke, IG Ovsyannikova, GA Poland, RB Kennedy
Immunity & ageing 16, 1-16, 2019
4142019
Fine mapping causal variants with an approximate Bayesian method using marginal test statistics
W Chen, BR Larrabee, IG Ovsyannikova, RB Kennedy, IH Haralambieva, ...
Genetics 200 (3), 719-736, 2015
2362015
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
IG Ovsyannikova, IH Haralambieva, SN Crooke, GA Poland, RB Kennedy
Immunological reviews 296 (1), 205-219, 2020
2252020
Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade
E Davila, R Kennedy, E Celis
Cancer research 63 (12), 3281-3288, 2003
2242003
Personalized vaccinology: a review
GA Poland, IG Ovsyannikova, RB Kennedy
Vaccine 36 (36), 5350-5357, 2018
1792018
Development of vaccines against Zika virus
GA Poland, RB Kennedy, IG Ovsyannikova, R Palacios, PL Ho, J Kalil
The Lancet Infectious Diseases 18 (7), e211-e219, 2018
1732018
SARS-CoV-2 vaccine development: current status
GA Poland, IG Ovsyannikova, SN Crooke, RB Kennedy
Mayo Clinic Proceedings 95 (10), 2172-2188, 2020
1512020
Prevention of monkeypox with vaccines: a rapid review
GA Poland, RB Kennedy, PK Tosh
The Lancet Infectious Diseases 22 (12), e349-e358, 2022
1372022
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?
GA Poland, RB Kennedy, IG Ovsyannikova
PLoS pathogens 7 (12), e1002344, 2011
1372011
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century
GA Poland, RB Kennedy, BA McKinney, IG Ovsyannikova, ND Lambert, ...
Seminars in immunology 25 (2), 89-103, 2013
1262013
Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses
HIPC-CHI Signatures Project Team, HIPC-I Consortium
Science immunology 2 (14), eaal4656, 2017
1242017
Systems biology approaches to new vaccine development
AL Oberg, RB Kennedy, P Li, IG Ovsyannikova, GA Poland
Current opinion in immunology 23 (3), 436-443, 2011
1242011
The immunology of smallpox vaccines
RB Kennedy, IG Ovsyannikova, RM Jacobson, GA Poland
Current opinion in immunology 21 (3), 314-320, 2009
1212009
Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function
RL Giuntoli, J Lu, H Kobayashi, R Kennedy, E Celis
Clinical cancer research 8 (3), 922-931, 2002
1192002
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
C Pawlowski, A Puranik, H Bandi, AJ Venkatakrishnan, V Agarwal, ...
Scientific reports 11 (1), 4741, 2021
1182021
The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches
IH Haralambieva, IG Ovsyannikova, VS Pankratz, RB Kennedy, ...
Expert review of vaccines 12 (1), 57-70, 2013
1162013
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections
GA Poland, IG Ovsyannikova, RB Kennedy, IH Haralambieva, ...
Omics: a journal of integrative biology 15 (9), 625-636, 2011
1112011
A systems biology approach to the effect of aging, immunosenescence and vaccine response
GA Poland, IG Ovsyannikova, RB Kennedy, ND Lambert, JL Kirkland
Current opinion in immunology 29, 62-68, 2014
1102014
The system can't perform the operation now. Try again later.
Articles 1–20